Up next

Autoplay

Emerging Agents in the Pipeline for Merkel Cell Carcinoma

3 Views • 07/17/23
Share
Embed
administrator
administrator
Subscribers
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay